A Study of Enzalutamide and LY3023414 in Men With Prostate Cancer

Associated Medical Professionals of NY, Syracuse

Univ of Pittsburgh Cancer Inst. (UPCI), Pittsburgh

Urological Associates of Lancaster, Lancaster

Virginia Cancer Specialists, Fairfax

University of Virginia Health System, Charlottesville

Virginia Oncology Associates, Norfolk

Carolina Urologic Research Center, Myrtle Beach

Florida Cancer Specialists East, West Palm Beach

Florida Cancer Specialists North, St. Petersburg

Florida Cancer Specialists, Fort Myers

Urology Centers of Alabama, P.C., Homewood

Sarah Cannon Research Institute SCRI, Nashville

Tennessee Oncology PLLC, Nashville

Urology Associates, Nashville

Cleveland Clinic Foundation, Cleveland

Oncology Hematology Care Inc, Cincinnati

Fort Wayne Oncology & Hematology, Fort Wayne

Medical College of Wisconsin, Milwaukee

Minnesota Oncology/Hematology PA, Minneapolis

Ingalls Memorial Hospital, Harvey

Urology Cancer Center, Omaha

Highlands Oncology Group, Fayetteville

Southwestern Medical Center - Dallas, Dallas

Texas Oncology-Baylor Charles A. Sammons Cancer Center, Fort Worth

Texas Oncology-Memorial City, Houston

US Oncology, The Woodlands

Comprehensive Cancer Centers of Nevada, Las Vegas

Prostate Oncology Specialists, Marina del Rey

Sharp Memorial Hospital, San Diego

Northwest Cancer Specialists PC, Tualatin

Oregon Urology Institute, Springfield

Swedish Medical Center, Seattle

Indiana Cancer Pavilion, Indianapolis

Dana Farber Cancer Institute, Boston

Garden State Urology, Morristown

Delaware Valley Urology, Voorhees Township